Color Health is betting its future on providing cancer care, not just testing. Burlingame, California-based Color got its ...
A new study out of Harvard Medical School and West Virginia University suggests that fighting prescription drug patents ...
March means the NCAA Tournament in the sports world, and Exact Sciences is hoping to inspire middle-aged fans to get screened ...
Just as insulin manufacturers were pressured into capping monthly out-of-pocket costs, inhaler manufacturers ...
The FDA approved a gene therapy known as Lenmeldy for early-onset metachromatic leukodystrophy, or MLD, a rare and ...
Regeneron on Monday successfully flipped a lower court’s decision in a hotly-contested case against Novartis ...
WuXi AppTec’s annual report on Monday reveals what’s at stake for the Shanghai-based service provider if the ...
This week, we’re launching Post-Hoc. Written by our reporters and editors, Post-Hoc is a weekly(ish) piece of analysis ...
The biopharmaceutical industry is a fascinating and cyclical ecosystem. Despite the stiff economic headwinds ...
Clinical-stage biotech Contineum Therapeutics, which until recently went by the name Pipeline Therapeutics, on Friday ...
In a win for Arkansas and the federal drug discount program known as 340B, a federal appeals court said the state can block ...
Former Theseus executives are now steering the ship at Ben Auspitz and Alexis Borisy's IDRx as the biotech looks to continue ...